Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review
Introduction: Antiviral drugs have been extensively used as a potential treatment during the COVID-19 pandemic. Based on previous studies, there were concerns about some of these drugs’ ototoxic and vestibulotoxic effects. Still, these concerns were exacerbated by the widespread use of these drugs...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2023-07-01
|
| Series: | Journal of Modern Rehabilitation |
| Subjects: | |
| Online Access: | https://jmr.tums.ac.ir/index.php/jmr/article/view/701 |
| _version_ | 1828718294208610304 |
|---|---|
| author | Vida Rahimi Elham Tavanai Mohammad Ehsan Khalili Ghassem Mohammadkhani |
| author_facet | Vida Rahimi Elham Tavanai Mohammad Ehsan Khalili Ghassem Mohammadkhani |
| author_sort | Vida Rahimi |
| collection | DOAJ |
| description |
Introduction: Antiviral drugs have been extensively used as a potential treatment during the COVID-19 pandemic. Based on previous studies, there were concerns about some of these drugs’ ototoxic and vestibulotoxic effects. Still, these concerns were exacerbated by the widespread use of these drugs at the beginning of the COVID-19 pandemic. Therefore, this article was done to comprehensively review the effects of ototoxicity and vestibulotoxicity of chloroquine (CQ)/hydroxychloroquine (HCQ) and remdesivir with different administration models and compare with the COVID-19 treatment guidelines in the world and Iran.
Materials and Methods: This study collected the related published studies in PubMed, Scopus, Google Scholar, and Web of Science with the main keywords “chloroquine”, “hydroxychloroquine”, “remdesivir”, “ototoxicity”, “vestibulotoxicity”, and “COVID-19”.
Results: The dose or duration of used HCQ/CQ drugs that caused ototoxic or vestibulotoxic effects in some diseases was reported mainly more than in COVID-19 guidelines, especially in Iran. These findings align with a recent study on slight HCQ-induced ototoxicity in patients with COVID-19 at low doses and short lengths of use. No evidence of possible cochlear damage after taking remdesivir is reported.
Conclusion: It seems that the concern about the ototoxic effects of some drugs used in the COVID-19 pandemic should be according to some factors that affect the pharmacological effects of drugs, such as dose, length of use, and co-administration of drugs. Therefore, lower dosage and length of use in some administration models in COVID-19 treatment, such as Iran, are associated with limited and reversible ototoxicity effects. However, further studies are needed.
|
| first_indexed | 2024-03-12T14:41:38Z |
| format | Article |
| id | doaj.art-0182038580534b4cb6c295fd48125792 |
| institution | Directory Open Access Journal |
| issn | 2538-385X 2538-3868 |
| language | English |
| last_indexed | 2024-03-12T14:41:38Z |
| publishDate | 2023-07-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | Journal of Modern Rehabilitation |
| spelling | doaj.art-0182038580534b4cb6c295fd481257922023-08-16T06:16:33ZengTehran University of Medical SciencesJournal of Modern Rehabilitation2538-385X2538-38682023-07-0117310.18502/jmr.v17i3.13062Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update ReviewVida Rahimi0Elham Tavanai1Mohammad Ehsan Khalili2Ghassem Mohammadkhani3Department of Audiology, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.ِDepartment of Audiology, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.ِDepartment of Audiology, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.Department of Audiology, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran. Introduction: Antiviral drugs have been extensively used as a potential treatment during the COVID-19 pandemic. Based on previous studies, there were concerns about some of these drugs’ ototoxic and vestibulotoxic effects. Still, these concerns were exacerbated by the widespread use of these drugs at the beginning of the COVID-19 pandemic. Therefore, this article was done to comprehensively review the effects of ototoxicity and vestibulotoxicity of chloroquine (CQ)/hydroxychloroquine (HCQ) and remdesivir with different administration models and compare with the COVID-19 treatment guidelines in the world and Iran. Materials and Methods: This study collected the related published studies in PubMed, Scopus, Google Scholar, and Web of Science with the main keywords “chloroquine”, “hydroxychloroquine”, “remdesivir”, “ototoxicity”, “vestibulotoxicity”, and “COVID-19”. Results: The dose or duration of used HCQ/CQ drugs that caused ototoxic or vestibulotoxic effects in some diseases was reported mainly more than in COVID-19 guidelines, especially in Iran. These findings align with a recent study on slight HCQ-induced ototoxicity in patients with COVID-19 at low doses and short lengths of use. No evidence of possible cochlear damage after taking remdesivir is reported. Conclusion: It seems that the concern about the ototoxic effects of some drugs used in the COVID-19 pandemic should be according to some factors that affect the pharmacological effects of drugs, such as dose, length of use, and co-administration of drugs. Therefore, lower dosage and length of use in some administration models in COVID-19 treatment, such as Iran, are associated with limited and reversible ototoxicity effects. However, further studies are needed. https://jmr.tums.ac.ir/index.php/jmr/article/view/701Severe acute respiratory syndrome coronavirus (SARS-CoV-2)COVID-19Ototoxic drugsHearing lossAntiviral drugs |
| spellingShingle | Vida Rahimi Elham Tavanai Mohammad Ehsan Khalili Ghassem Mohammadkhani Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review Journal of Modern Rehabilitation Severe acute respiratory syndrome coronavirus (SARS-CoV-2) COVID-19 Ototoxic drugs Hearing loss Antiviral drugs |
| title | Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review |
| title_full | Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review |
| title_fullStr | Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review |
| title_full_unstemmed | Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review |
| title_short | Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review |
| title_sort | ototoxic and vestibulotoxic effects of chloroquine hydroxychloroquine and remdesivir in the treatment of covid 19 update review |
| topic | Severe acute respiratory syndrome coronavirus (SARS-CoV-2) COVID-19 Ototoxic drugs Hearing loss Antiviral drugs |
| url | https://jmr.tums.ac.ir/index.php/jmr/article/view/701 |
| work_keys_str_mv | AT vidarahimi ototoxicandvestibulotoxiceffectsofchloroquinehydroxychloroquineandremdesivirinthetreatmentofcovid19updatereview AT elhamtavanai ototoxicandvestibulotoxiceffectsofchloroquinehydroxychloroquineandremdesivirinthetreatmentofcovid19updatereview AT mohammadehsankhalili ototoxicandvestibulotoxiceffectsofchloroquinehydroxychloroquineandremdesivirinthetreatmentofcovid19updatereview AT ghassemmohammadkhani ototoxicandvestibulotoxiceffectsofchloroquinehydroxychloroquineandremdesivirinthetreatmentofcovid19updatereview |